GRANTS

274 RESULTS

To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3) - Clinical Trial Optional

Sponsor: National Institutes of Health

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: February 7, 2018, August 9, 2018, February 9, 2019, August 9, 2019, February 11, 2020, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Academic Research Enhancement Award (Parent R15 Clinical Trial Not Allowed)

Sponsor: National Institutes of Health

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for this FOA is February 25, 2018.

Program to Accelerate Clinical Trials (PACT)

Sponsor: Alzheimer's Drug Discovery Foundation

Award: Up to $3 million based on stage and scope of research. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged.

Due Date: January 19, 2018. Must be received by 5 p.m. EST on the deadline date.

Prevention Beyond the Pipeline

Sponsor: Alzheimer's Drug Discovery Foundation

Award: Up to $3 million based on stage and scope of research.

Due Date: January 19, 2018. Must be received by 5 p.m. EST on the deadline date.

Drug Discovery

Sponsor: Alzheimer's Drug Discovery Foundation

Award: $150,000-$600,000 based on stage and scope of research.

Due Date: January 19, 2018. Must be received by 5 p.m. EST on the deadline date.

Biomarkers Development

Sponsor: Alzheimer's Drug Discovery Foundation

Award: $150,000-$300,000 based on stage and scope of research.

Due Date: January 19, 2018. Must be received by 5 p.m. EST on the deadline date.

BRAIN Initiative: Biology and Biophysics of Neural Stimulation (R01 - Clinical Trials Optional)

Sponsor: National Institutes of Health

Award: NIH anticipates providing $5 million per year to fund an estimated five to 10 awards

Due Date: February 23, 2018, June 6, 2018, October 4, 2018, February 6, 2019, June 4, 2019, October 4, 2019, February 6, 2020, June 4, 2020, and October 6, 2020, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimers Disease Risk (R01 - Clinical Trial Not Allowed)

Sponsor: National Institute on Aging

Award: NIA intends to commit $4.5 million in FY 2018 to fund three or four awards. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: March 26, 2018), by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Pragmatic Trials of Managing Multimorbidity in Alzheimers Disease (R01 Clinical Trial Required)

Sponsor: National Institute on Aging

Award: NIA intends to commit $3.2 million in FY 2018 to fund two to four awards. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: March 26, 2018, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Exosomes: From Biogenesis and Secretion to the Early Pathogenesis of Alzheimer's Disease (R01 - Clinical Trial Not Allowed)

Sponsor: National Institute on Aging

Award: NIA intends to commit $8 million in FY 2018 to fund nine to 11 awards. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: March 26, 2018, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Pragmatic Trials of Managing Multimorbidity in Alzheimers Disease (R01 Clinical Trial Required)

Sponsor: National Institute on Aging

Award: NIA intends to commit $3.2 million in FY 2018 to fund two to four awards. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: March 26, 2018, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

From Association to Function in the Alzheimers Disease Post-Genomics Era (R01 - Clinical Trial Not Allowed)

Sponsor: National Institute on Aging

Award: NIA intends to commit $3.5 million in FY 2018 to fund six to eight awards. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: March 28, 2018, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Current Filters

No filters selected

Filter By